BUILD 3: Bosentan Use in Interstitial Lung Disease

NCT00391443 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

616

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Bosentan
DRUG: Placebo

Sponsor

Actelion